{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-010006","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2025-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.482553+00:00","generated_at":"2026-05-21T16:43:44.907202+00:00","sec_items":["2.02","5.02","5.07","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Intelligent Bio Solutions Q3 revenue $0.73M, up 20% QoQ; gross profit up 91% YoY","bullets":["Revenue $0.73M in fiscal Q3, up 20% sequentially; nine-month revenue $2.21M, down 7% YoY.","Gross profit $341,368, up 91% YoY; cartridge sales now 58% of total revenue for nine months.","Net loss attributable to company $2.54M, down from $2.98M YoY; cash $2.81M.","Added 35 new accounts in Q3, active customers exceed 450; launched multilingual system upgrades."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-010006","json":"https://secwatch.observer/filing/0001641172-25-010006.json","markdown":"https://secwatch.observer/filing/0001641172-25-010006.md","text":"https://secwatch.observer/filing/0001641172-25-010006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000164117225010006/0001641172-25-010006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000164117225010006/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-21T16:43:44.907202+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}